The Role of Whole-Body Positron Emission Tomography With [18F]Fluorodeoxyglucose in Identifying Operable Colorectal Cancer Metastases to the Liver

David T. M. Lai, MBBS; Michael Fulham, MBBS, FRACP; Michael S. Stephen, MBBS, FRACS; Kent-Man Chu, MBBS, FRCS; Michael Solomon, MBBCh, BAO, FRACS; John F. Thompson, MBBS, FRACS; Donald M. Sheldon, MBBS, FRACS; David W. Storey, MBBS, FRCS, FRACS
Arch Surg. 1996;131(7):703-707. doi:10.1001/archsurg.1996.01430190025007.
Text Size: A A A
Published online

Objective:  To compare the accuracy of whole-body positron emission tomography (PET)using [18F]fluorodeoxyglucose (FDG) with conventional radiological imaging techniques in identifying operable colorectal cancer metastases to the liver.

Design:  A double-blind comparative study of FDG-PET as the criterion standard vs conventional radiological imaging methods as the criterion standard, in staging of recurrent colorectal cancer.

Setting:  Institutional practice in a tertiary referral center.

Patients:  Thirty-four consecutive patients with suspected colorectal cancer metastases, recruited for the study between May 1993 and October 1994.

Interventions:  Conventional radiological methods of cancer staging included abdominal computed tomography (CT) (n=34), chest x-rays (n=15), and chest CT (n=19) to evaluate extrahepatic disease. Twenty-seven patients were subsequently considered to have apparently isolated cancer metastases to the liver. Anatomical resectability was assessed by magnetic resonance imaging (n=24) or CT angiography (n=3) in all study patients. The FDG-PET studies (n=34) were performed within 8 weeks of conventional radiological imaging.

Main Outcome Measures:  Malignancy of suspected lesions detected by means of FDG-PET and conventional radiological imaging was confirmed by histopathologic examination of resected specimens and percutaneous biopsy specimens and by serial CT scans demonstrating progression of disease.

Results:  Unsuspected extrahepatic malignant disease that was missed by conventional radiological imaging was detected by FDG-PET in 11 patients (32%). The PET-detected extrahepatic malignant disease included retroperitoneal nodal metastases (n=6), pulmonary metastases (n=3), and locoregional cancer recurrences (n=2). The additional information afforded by PET consequently had an influence on the clinical management in 10 patients (29%).

Conclusion:  The FDG-PET method enabled selection of patients with apparently curable colorectal cancer metastases to the liver for hepatic resection.Arch Surg. 1996;131:703-707


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.